Advertisement

Topics

Thrombosis - Pipeline Review, H1 2015

07:44 EDT 11 Aug 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Thrombosis - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-06-29. This 271-page report is available in PDF from $2000.

Thrombosis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Thrombosis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Thrombosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombosis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Thrombosis
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Thrombosis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Thrombosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Thrombosis pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and…

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 9
Global Markets Direct Report Coverage 9
Thrombosis Overview 10
Therapeutics Development 11
Pipeline Products for Thrombosis - Overview 11
Pipeline Products for Thrombosis - Comparative Analysis 12
Thrombosis - Therapeutics under Development by Companies 13
Thrombosis - Therapeutics under Investigation by Universities/Institutes 18
Thrombosis - Pipeline Products Glance 21
Late Stage Products 21
Clinical Stage Products 22
Early Stage Products 23
Thrombosis - Products under Development by Companies 24
Thrombosis - Products under Investigation by Universities/Institutes 30
Thrombosis - Companies Involved in Therapeutics Development 33
Archemix Corp. 33
Arena Pharmaceuticals, Inc. 34
Armetheon, Inc. 35
Arrowhead Research Corporation 36
Astellas Pharma Inc. 37
AstraZeneca Plc 38
Bayer AG 39
Bristol-Myers Squibb Company 40
Cardax Pharmaceuticals, Inc. 41
Cereno Scientific AB 42
China Biologic Products, Inc. 43
CSL Limited 44
Daewoong Pharmaceutical Co., Ltd. 45
Daiichi Sankyo Company, Limited 46
Eisai Co., Ltd. 47
F. Hoffmann-La Roche Ltd. 48
Gamma Therapeutics, Inc. 49
Generex Biotechnology Corporation 50
GlycoMimetics, Inc. 51
Green Cross Corporation 52
IMMD Inc. 53
Isis Pharmaceuticals, Inc. 54
Johnson & Johnson 55
Laboratorios Farmaceuticos Rovi, S.A. 56
LG Life Sciences, Ltd. 57
Lipicard Technologies Limited 58
Merrion Pharmaceuticals Plc 59
Nostrum Pharmaceuticals, LLC 60
Pfizer Inc. 61
PLx Pharma Inc. 62
Portola Pharmaceuticals, Inc. 63
Prothix BV 64
Sagene Pharmaceuticals, Inc. 65
Sanofi 66
SciFluor Life Sciences, LLC 67
Tobira Therapeutics, Inc. 68
Zedira GmbH 69
Thrombosis - Therapeutics Assessment 70
Assessment by Monotherapy Products 70
Assessment by Combination Products 71
Assessment by Target 72
Assessment by Mechanism of Action 76
Assessment by Route of Administration 80
Assessment by Molecule Type 82
Drug Profiles 84
AB-012 - Drug Profile 84
antithrombin III (human) - Drug Profile 86
ANV-6L15 - Drug Profile 87
apixaban - Drug Profile 88
ARC-15105 - Drug Profile 90
ARCF-12 - Drug Profile 91
AS-1468240 - Drug Profile 92
ASP-1645 - Drug Profile 93
ASP-6537 - Drug Profile 94
aspirin - Drug Profile 95
BAY-1213790 - Drug Profile 97
betrixaban - Drug Profile 98
BMS-262084 - Drug Profile 100
BMS-593214 - Drug Profile 101
BMS-816106 - Drug Profile 102
BMS-884775 - Drug Profile 103
BMS-986120 - Drug Profile 104
BMS-986141 - Drug Profile 105
C-3 - Drug Profile 106
CDX-085 - Drug Profile 107
CLB-100 - Drug Profile 109
CSL-312 - Drug Profile 110
DD-2 - Drug Profile 111
Drug to Activate Endothelial Protein C Receptor for Inflammation and Thrombosis …

For more information open Thrombosis - Pipeline Review, H1 2015.

SKU: GMDHC6511IDB

Original Article: Thrombosis - Pipeline Review, H1 2015

NEXT ARTICLE

More From BioPortfolio on "Thrombosis - Pipeline Review, H1 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...